A detailed history of Jacobi Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jacobi Capital Management LLC holds 7,935 shares of NVO stock, worth $1.13 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,935
Previous 7,645 3.79%
Holding current value
$1.13 Million
Previous $790,000 28.86%
% of portfolio
0.09%
Previous 0.08%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $29,611 - $39,416
290 Added 3.79%
7,935 $1.02 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $255,527 - $306,964
2,911 Added 61.49%
7,645 $790,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $290,007 - $636,333
3,189 Added 206.41%
4,734 $430,000
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $7,331 - $8,114
47 Added 3.14%
1,545 $250,000
Q1 2023

May 05, 2023

SELL
$132.34 - $159.14 $35,996 - $43,286
-272 Reduced 15.37%
1,498 $238,000
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $181,513 - $239,534
1,770 New
1,770 $239,000
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $113,042 - $138,037
-1,179 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $337 - $426
4 Added 0.34%
1,179 $113,000
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $473 - $593
7 Added 0.6%
1,175 $98,000
Q1 2021

May 11, 2021

BUY
$67.06 - $75.82 $5,498 - $6,217
82 Added 7.55%
1,168 $79,000
Q4 2020

Feb 08, 2021

BUY
$63.89 - $73.8 $2,172 - $2,509
34 Added 3.23%
1,086 $76,000
Q3 2020

Oct 30, 2020

BUY
$63.69 - $70.22 $254 - $280
4 Added 0.38%
1,052 $73,000
Q2 2020

Aug 04, 2020

BUY
$58.54 - $67.94 $42,617 - $49,460
728 Added 227.5%
1,048 $69,000
Q2 2020

Jul 27, 2020

SELL
$58.54 - $67.94 $42,207 - $48,984
-721 Reduced 69.26%
320 $69,000
Q1 2020

Apr 24, 2020

BUY
$49.46 - $64.78 $1,088 - $1,425
22 Added 2.16%
1,041 $63,000
Q3 2019

Nov 12, 2019

BUY
$47.54 - $53.43 $237 - $267
5 Added 0.49%
1,019 $53,000
Q2 2019

Aug 07, 2019

BUY
$46.79 - $52.47 $374 - $419
8 Added 0.8%
1,014 $52,000
Q1 2019

May 13, 2019

BUY
$46.36 - $52.63 $11,404 - $12,946
246 Added 32.37%
1,006 $53,000
Q4 2018

Feb 11, 2019

SELL
$41.54 - $47.25 $75,478 - $85,853
-1,817 Reduced 70.51%
760 $35,000
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $85,196 - $93,359
1,822 Added 241.32%
2,577 $121,000
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $398 - $453
9 Added 1.21%
755 $35,000
Q1 2018

May 03, 2018

BUY
$48.49 - $58.14 $1,939 - $2,325
40 Added 5.67%
746 $36,000
Q3 2017

Nov 02, 2017

BUY
$41.15 - $49.22 $19,546 - $23,379
475 Added 205.63%
706 $35,000
Q2 2017

Aug 10, 2017

BUY
N/A
231
231 $10,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Jacobi Capital Management LLC Portfolio

Follow Jacobi Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.